N-[1-(3-{3-[4-(1-aminocyclobutyl)phenyl]-2-(2-aminopyridin-3-yl)-3H-imidazo[4,5-b]pyridin-5-yl}phenyl)piperidin-4-yl]-N-methylacetamide
Structure Info
- Chemspace ID
- CSSB06354209259 (In-Stock Building Blocks)
- IUPAC Name
- N-[1-(3-{3-[4-(1-aminocyclobutyl)phenyl]-2-(2-aminopyridin-3-yl)-3H-imidazo[4,5-b]pyridin-5-yl}phenyl)piperidin-4-yl]-N-methylacetamide
- Mol formula
- C35H38N8O
- Mol weight
- 587 Da
- Catalog Number(s)
- 1416775-46-6, AA023OCN, AD279670, AG023OFF, BJ30659, HY-137458, ST023PW7, T38847, TX023PL3
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 4.22
- Heavy atoms count
- 44
- Rotatable bond count
- 6
- Number of rings
- 7
- Carbon bond saturation, Fsp3
- 0.314
- Polar surface area (Å)
- 119
- Hydrogen bond acceptors count
- 7
- Hydrogen bond donors count
- 2
![Chemical structure of N-[1-(3-{3-[4-(1-aminocyclobutyl)phenyl]-2-(2-aminopyridin-3-yl)-3H-imidazo[4,5-b]pyridin-5-yl}phenyl)piperidin-4-yl]-N-methylacetamide (C35H38N8O) - CSSB06354209259](/st/structure/200/69aa4e0bf2b4f8d6b95490f9ac500409/CN%2528C1CCN%2528CC1%2529c1cccc%2528c1%2529-c1ccc2nc%2528-c3cccnc3N%2529n%2528-c3ccc%2528cc3%2529C3%2528N%2529CCC3%2529c2n1%2529C%2528C%2529%253DO.png "C35H38N8O")
- Zoom the structure
- CSSB06354209259
Items Overall 15 items from 4 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| 1st Scientific LLC | 7 days | United States To: | 98 | 5 mg | 578.60 | |
| 1st Scientific LLC | 7 days | United States To: | 98 | 10 mg | 1,039.50 | |
| 1st Scientific LLC | 7 days | United States To: | 98 | 25 mg | 2,239.60 | |
| 1st Scientific LLC | 7 days | United States To: | 98 | 50 mg | 4,096.40 | |
Description: ARQ-751; CAS: 1416775-46-6 | ||||||
| Advanced ChemBlocks CN | 10 days | China To: | 98 | 1 mg | 190.00 | |
| Advanced ChemBlocks CN | 10 days | China To: | 98 | 5 mg | 475.00 | |
| Advanced ChemBlocks CN | 10 days | China To: | 98 | 25 mg | 1,980.00 | |
Description: Vevorisertib; CAS: 1416775-46-6 | ||||||
| A2B Chem | 12 days | United States To: | 98 | 5 mg | 671.60 | |
| A2B Chem | 12 days | United States To: | 98 | 10 mg | 1,206.35 | |
| A2B Chem | 12 days | United States To: | 98 | 25 mg | 2,601.30 | |
| A2B Chem | 12 days | United States To: | 98 | 50 mg | 4,757.55 | |
Description: ARQ-751; CAS: 1416775-46-6 | ||||||
| 10X CHEM | TBD | United States To: | 98 | 5 mg | 595.10 | |
| 10X CHEM | TBD | United States To: | 98 | 10 mg | 1,070.30 | |
| 10X CHEM | TBD | United States To: | 98 | 25 mg | 2,310.00 | |
| 10X CHEM | TBD | United States To: | 98 | 50 mg | 4,227.30 | |
Description: ARQ-751; CAS: 1416775-46-6 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Substructure Analogs
![Chemical structure of N-[1-(3-{3-[4-(1-aminocyclobutyl)phenyl]-2-(2-aminopyridin-3-yl)-3H-imidazo[4,5-b]pyridin-5-yl}phenyl)piperidin-4-yl]-N-methylacetamide trihydrochloride - CSSB06446547648](/st/structure/200/1d499951e91ea8f7114f6ce8d0dd532c/Cl.Cl.Cl.CN%2528C1CCN%2528CC1%2529c1cccc%2528c1%2529-c1ccc2nc%2528-c3cccnc3N%2529n%2528-c3ccc%2528cc3%2529C3%2528N%2529CCC3%2529c2n1%2529C%2528C%2529%253DO.png)
Similarity Analogs
![Chemical structure of 3-{3-[4-(1-aminocyclobutyl)phenyl]-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl}pyridin-2-amine trihydrochloride - CSSB00102885900](/st/structure/200/31c88524d458937d7538533e4c4b8b0f/Cl.Cl.Cl.NC1%253DNC%253DCC%253DC1C1%253DNC2%253DCC%253DC%2528N%253DC2N1C1%253DCC%253DC%2528C%253DC1%2529C1%2528N%2529CCC1%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of 3-{3-[4-(1-aminocyclobutyl)phenyl]-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl}pyridin-2-amine hydrochloride - CSSB00134618228](/st/structure/200/09b220c7d73b5e72350343372978a737/Cl.NC1%253DNC%253DCC%253DC1C1%253DNC2%253DCC%253DC%2528N%253DC2N1C1%253DCC%253DC%2528C%253DC1%2529C1%2528N%2529CCC1%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of 3-{3-[4-(1-aminocyclobutyl)phenyl]-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl}pyridin-2-amine - CSSB00102462624](/st/structure/200/c14c28ea174b947f1ad4305ddc3364d9/NC1%253DNC%253DCC%253DC1C1%253DNC2%253DCC%253DC%2528N%253DC2N1C1%253DCC%253DC%2528C%253DC1%2529C1%2528N%2529CCC1%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of 4-[4-amino-1-(1-{4-[cyclopropyl(methyl)amino]but-2-enoyl}pyrrolidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]-2-methoxy-N-(4-methylpyridin-2-yl)benzamide; 4-[4-amino-1-(1-{4-[cyclopropyl(methyl)amino]but-2-enoyl}pyrrolidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]-N-(4-ethylpyridin-2-yl)benzamide; 4-[4-amino-1-(1-{4-[cyclopropyl(methyl)amino]but-2-enoyl}pyrrolidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]-N-(5-methyl-1,3-thiazol-2-yl)benzamide - CSSB20620666382](/st/structure/200/82398270968a8e6929fdfa8fc015c644/CN%2528CC%253DCC%2528%253DO%2529N1CCC%2528C1%2529N1N%253DC%2528C2%253DC%2528N%2529N%253DCN%253DC12%2529C1%253DCC%253DC%2528C%253DC1%2529C%2528%253DO%2529NC1%253DNC%253DC%2528C%2529S1%2529C1CC1.CCC1%253DCC%253DNC%2528NC%2528%253DO%2529C2%253DCC%253DC%2528C%253DC2%2529C2%253DNN%2528C3CCN%2528C3%2529C%2528%253DO%2529C%253DCCN%2528C%2529C3CC3%2529C3%253DNC%253DNC%2528N%2529%253DC23%2529%253DC1.COC1%253DCC%2528%253DCC%253DC1C%2528%253DO%2529NC1%253DCC%2528C%2529%253DCC%253DN1%2529C1%253DNN%2528C2CCN%2528C2%2529C%2528%253DO%2529C%253DCCN%2528C%2529C2CC2%2529C2%253DNC%253DNC%2528N%2529%253DC12.png)
![Chemical structure of 4-(4-amino-1-{1-[(2E)-4-[cyclopropyl(methyl)amino]but-2-enoyl]pyrrolidin-3-yl}-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-2-methoxy-N-(4-methylpyridin-2-yl)benzamide; 4-(4-amino-1-{1-[(2E)-4-[cyclopropyl(methyl)amino]but-2-enoyl]pyrrolidin-3-yl}-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-N-(4-ethylpyridin-2-yl)benzamide; 4-(4-amino-1-{1-[(2E)-4-[cyclopropyl(methyl)amino]but-2-enoyl]pyrrolidin-3-yl}-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-N-(5-methyl-1,3-thiazol-2-yl)benzamide - CSSB21509664025](/st/structure/200/099d9f66fefff4064065bc691739ed08/CN%2528C%255CC%253DC%255CC%2528%253DO%2529N1CCC%2528C1%2529N1N%253DC%2528C2%253DC%2528N%2529N%253DCN%253DC12%2529C1%253DCC%253DC%2528C%253DC1%2529C%2528%253DO%2529NC1%253DNC%253DC%2528C%2529S1%2529C1CC1.CCC1%253DCC%253DNC%2528NC%2528%253DO%2529C2%253DCC%253DC%2528C%253DC2%2529C2%253DNN%2528C3CCN%2528C3%2529C%2528%253DO%2529%255CC%253DC%255CCN%2528C%2529C3CC3%2529C3%253DNC%253DNC%2528N%2529%253DC23%2529%253DC1.COC1%253DCC%2528%253DCC%253DC1C%2528%253DO%2529NC1%253DCC%2528C%2529%253DCC%253DN1%2529C1%253DNN%2528C2CCN%2528C2%2529C%2528%253DO%2529%255CC%253DC%255CCN%2528C%2529C2CC2%2529C2%253DNC%253DNC%2528N%2529%253DC12.png)
![Chemical structure of tert-butyl (3S)-3-{3H-imidazo[4,5-b]pyridin-3-yl}pyrrolidine-1-carboxylate - CSSB00016992369](/st/structure/200/74dc4a3ee7baf2215de420290267fb9f/CC%2528C%2529%2528C%2529OC%2528%253DO%2529N1CC%255BC%2540%2540H%255D%2528C1%2529N1C%253DNC2%253DCC%253DCN%253DC12.png)
